our science
World’s first clinical nutrition portfolio supported by well-controlled safety + outcome studies.
Acute to Chronic
Clinically Focused Product Portfolio
Clinical nutrition portfolio supported by randomized placebo controlled trials. We will be with the patient from acute, to chronic conditions to wellbeing and healthy living.
Joint Replacement - Surgical Return to Function
Repair & Recover -Tissue Healing
Control: Glucose - Pre-Surgery & Daily Use
Regenerate - Sarcopenia + Frailty
Perform: Daily - Inflammation + Flexibility
Mend™ has invested in multiple third-party and user-reported clinical trials to show the importance and efficacy of our products.
Third Party Tested
Clinically Studied
Highest Bioavailability
Mechanism of Action
“Our strategy was to create 'Nutrapharma,' ensuring our ingredients and products are safe and effective. Published in peer-reviewed journals, our studies reflect our collaboration with top universities and research institutions, providing the most comprehensive evidence on the market.”
Kim Biedermann, Ph.D.
Chief Science Officer at Mend Nutrition
Our Scientific Approach
Our Scientific Approach
Identify Needs 1
Monitoring the latest research and working with our ecosystem to identify new and emerging needs.
Develop Solutions 2
Working with our network of advisors, partners, and clients, to develop novel targeted solutions.
Validate Through Clinical Trials 3
Putting our solutions through multiple double blind randomized trials to validate safety and efficacy.
Research Studies
Clinical Results + Research-Backed Formulas
mend™ Joint Replacement has been shown in 3 double-blind placebo controlled randomized trials to preserve muscle and improve return to function after surgery.
This potent nature-powered formula optimizes the sugar levels in your body. It stops the spikes and crashes caused by processed food and hidden sugars, helping to balance your mood and energy.
Fuel your body to get well sooner after surgery, injury, and the strain of intense exercise.
Whether it’s intense exercise or daily wear and tear, this complex blend of 33 nature-powered nutrients puts back in to your body what life takes out.
Research & Development
We take pride in our clinically focused approach to product development. Our science board and partners have been instrumental in building the first clinically studied comprehensive perioperative nutrition portfolio on the market.
Featured Studies
Nutrition Supplementation to Improve Muscle Physiology for Older Adults with Hip Fracture
Mend is proud to support an investigator initiated research project led by Dr. Mike Willey in the Department of Orthopedics & Rehabilitation at the University of Iowa Health Care. The project is being conducted in collaboration with Dr. Hans Dreyer in the Department of Human Physiology at the University of Oregon and Dr. Daniel Fitzpatrick at the Slocum Foundation, Eugene, Oregon. The team aims to evaluate the clinical and mechanistic outcomes of administering Mend Repair & Recover Surgery, a medical food, to patients undergoing surgical repair of hip fracture in a randomized, no-treatment controlled trial.
Mend is proud to collaborate with an investigator-initiated research project led by Drs. Jacob Earp and Cristina Colón-Semenza in the Department of Kinesiology at the University of Connecticut titled Comparison of whey protein and amino acid supplementation on amino acid and levodopa concentrations in people with Parkinson’s disease. This Food and Drug Administration (FDA) Investigational New Drug (IND) approved research project, funded by the University of Connecticut's Research Excellent Program, will investigate the use of a unique amino acid formulation manufactured by Mend to provide targeted nutritional supplementation of amino acids commonly deficient in people with Parkinson's disease while minimizing interaction with levodopa medications.
Our Scientific Advisory Board
Our healing products are designed by leading experts.
Paul Wischmeyer MD, EDIC, FASPEN, FCCM
Hans Dreyer PhD, PT
Jenn Randazzo RD
Douglas Jacoby, MD
Vinod Dasa, MD
Robert Marx, MD
Michael Suk, MD, JD, MPH, MBA
Andrew Wickline, MD
Paul Wischmeyer MD, EDIC, FASPEN, FCCM
Paul Wischmeyer M.D., EDIC, FASPEN, FCCM is a nutrition, exercise, critical care, and perioperative physician-researcher who specializes in enhancing preparation and recovery from surgery, critical care and COVID-19. He serves as a Tenured Professor of Anesthesiology and Surgery at Duke.
Hans Dreyer PhD, PT
Hans Dreyer is an academic expert in metabolism, muscle physiology and physical rehabilitation. His current research, funded by the National Institutes of Health, looks at the effects of total knee replacements on muscle physiology and metabolism. The goal of the project is to develop strategies to preserve and help rebuild muscle throughout the surgical process. His past research found that the use of essential amino acids reduces muscle losses and promotes a speedier recovery in patients requiring total knee replacement surgery.
Jenn Randazzo RD
Jenn is an integrative and functional registered dietitian with 10+ years in the natural products industry helping brands bring meaningful products to market that consumers trust. As a co-founder of CRDIBLE, she’s committed to leveraging her nutrition and industry expertise to guide product ideation and formulation development.
Douglas Jacoby, MD
Douglas S. Jacoby, MD, FACC, FNLA is an Associate Professor of Clinical Medicine at the Perelman School of Medicine at the University of Pennsylvania. He serves as the medical director of the Penn Medicine Center for Preventive Cardiology and Lipid Management, which focuses on assessing and reducing all aspects of cardiovascular risk. Dr. Jacoby received both his undergraduate and medical degrees from Harvard University, and completed residency and a cardiology fellowship at the University of Pennsylvania. He practices both as a cardiologist and lipidologist.
Vinod Dasa, MD
Dr. Vinod Dasa completed his undergraduate and medical school in a seven year combined degree program at Union College and Albany Medical College in New York. After completing medical school, Dr. Dasa trained in the State University at New York (SUNY) at Buffalo orthopedic surgery residency program. In 2006 he furthered his training at the Insall Scott Kelly Institute, Manhattan, New York, in Sports Medicine and Joint Replacement Surgery. This fellowship is internationally recognized as one of the pioneers in total knee replacement surgery. After completing his fellowship Dr. Dasa and his wife decided to begin their careers as faculty at LSU Health Sciences Center to help rebuild post-Katrina.
Robert Marx, MD
Dr. Robert Marx is an Orthopedic Surgeon at the Hospital for Special Surgery and Professor of Orthopedic Surgery at Weill Medical College of Cornell University. He is Vice Chair of Orthopedic Surgery for faculty development at the Hospital for Special Surgery. Dr. Marx has extensive experience in knee and shoulder surgery, with particular interest in ACL surgery, complex knee ligament reconstruction, and knee replacement. He has been voted as one of the “Best Doctors in New York” by New York Magazine for multiple years. Dr. Marx is the Head Consulting Orthopedic Surgeon for Ultimate Fighting Championship (UFC), The Juilliard School and a Team Physician for the New York Rangers.
Michael Suk, MD, JD, MPH, MBA
Michael Suk, MD, JD, MPH, MBA, a board-certified orthopaedic surgeon who was first elected to the American Medical Association Board of Trustees in June 2019, was elected chair-elect of the AMA in June 2023. Throughout his career, Dr. Suk has been a vocal leader on public health issues, including the role and importance of organized medicine, resident work hours, social determinants of health and numerous other public health concerns.
Andrew Wickline, MD
Dr. Wickline received his medical degree from Albany Medical Center (Albany, NY). He completed his residency in Orthopedic Surgery at Albany Medical Center (Albany, NY), and a fellowship in Joint Replacement at Cleveland Clinic (Cleveland, OH).